ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0905

Artificial Neural Network for the Recognition of Active Inflammatory Changes Compatible with Axial Spondyloarthritis on Magnetic Resonance Imaging of Sacroiliac Joints

Denis Poddubnyy1, Janis Vahldiek2, Lisa Adams2, Torsten Diekhoff2, Fabian Proft2, Mikhail Protopopov2, Judith Rademacher2, Valeria Rios Rodriguez2, Murat Torgutalp2, Stefan Niehues2 and Keno Bressem2, 1Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany, 2Charité University Medicine Berlin, Berlin, Germany

Meeting: ACR Convergence 2021

Keywords: Ankylosing spondylitis (AS), Magnetic resonance imaging (MRI), spondyloarthritis, Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster II: Imaging in Spondyloarthritis (0897–0907)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Active inflammatory changes in sacroiliac joints (SIJ) compatible with axial spondyloarthritis – axSpA (first of all, subchondral bone marrow edema – BME / osteitis) as detected by magnetic resonance imaging (MRI) play a pivotal role in diagnostic and classification approaches. Artificial intelligence/machine learning methods such as a trained artificial convolutional network (CNN) offer a potential for the development of assistant tools to be used by radiologists and rheumatologists in clinical practice.

The present study is aimed to evaluate the possibility of detection of active inflammatory changes compatible with axSpA on MRI of SIJ.

Methods: A total of 6 trained and calibrated readers evaluated MRIs of SIJ (STIR, semicoronal views) of 476 patients with and without axSpA from 4 cohorts (GESPIC-AS, GESPIC-Crohn, GESPIC-Uveitis, and OptiRef). Readers indicated the presence or absence of active inflammatory changes compatible with axSpA and specified the type of changes. Active inflammatory changes were considered present if at least 4 out of 6 readers deemed them positive. Images with an undetermined classification were adjudicated in a consensus reading session. These results were used for the training and validation of the CNN. First, we used an object detection approach to train a 3D CNN to detect the SIJ on all available MRIs to generate dilated masks of the SIJs to focus subsequent model training to the SIJs and periarticular areas. Secondly, we used a classification task to train a 2D CNN (ResNet34) to predict the presence of active inflammatory changes compatible with SpA on these grid MRI images. MRIs from the ASAS classification Cohort annotated by 7 readers (Maksymowych WP, at al. Ann Rheum Dis 2020;79:935-942) formed the holdout dataset that was used to test for CNN generalizability.

Results: A total of 403 STIR-MRIs were included in the training, 73 in the validation sets and 122 in the holdout set. The trained classification CNN achieved an accuracy of 91.8%, a sensitivity of 88.9% and a specificity of 93.5% in detecting active inflammatory changes in SIJ compatible with axSpA in the validation set (n=73). The accuracy of MRI classification in the independent holdout set (ASAS) was 81.5% with a sensitivity of 67% and a specificity of 84.5%. Figure 1 shows an exemplary class activation map of the CNN.

Conclusion: Our study shows the principal possibility of detecting active inflammatory changes compatible with axSpA on MRI of SIJs. Detection of structural changes and overall contextual interpretation of the findings are warranted for the subsequent development steps.

Acknowledgment. The project was supported by a research grant from ASAS. We want to thank colleagues who performed annotation of the images from the ASAS classification cohort: Xenofon Baraliakos, Robert Lambert, Pedro Machado, Walter Maksymowych, Mikkel Ostergaard, Suzanne Juhl Pedersen, and Ulrich Weber.


Disclosures: D. Poddubnyy, AbbVie, 2, 5, 6, Eli Lilly and Company, 2, 5, 6, MSD, 2, 5, 6, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, UCB, 2, 6, BMS, 2, 6, Roche, 2, 6; J. Vahldiek, None; L. Adams, None; T. Diekhoff, None; F. Proft, Novartis, 1, 5, 6, Eli Lilly and Company, 1, 5, UCB, 1, 5, 6, AbbVie, 1, 6, Amgen, 1, 6, Bristol-Myers Squibb, 1, 6, Hexal, 1, 6, MSD, 1, 6, Pfizer, 1, 6, Roche, 1, 6; M. Protopopov, Novartis, 1, 5, 6; J. Rademacher, None; V. Rios Rodriguez, None; M. Torgutalp, None; S. Niehues, None; K. Bressem, None.

To cite this abstract in AMA style:

Poddubnyy D, Vahldiek J, Adams L, Diekhoff T, Proft F, Protopopov M, Rademacher J, Rios Rodriguez V, Torgutalp M, Niehues S, Bressem K. Artificial Neural Network for the Recognition of Active Inflammatory Changes Compatible with Axial Spondyloarthritis on Magnetic Resonance Imaging of Sacroiliac Joints [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/artificial-neural-network-for-the-recognition-of-active-inflammatory-changes-compatible-with-axial-spondyloarthritis-on-magnetic-resonance-imaging-of-sacroiliac-joints/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/artificial-neural-network-for-the-recognition-of-active-inflammatory-changes-compatible-with-axial-spondyloarthritis-on-magnetic-resonance-imaging-of-sacroiliac-joints/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology